Bridgeway Capital Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-128,100
Closed -$3.8M 1271
2025
Q1
$3.8M Sell
128,100
-41,300
-24% -$1.57M 0.1% 307
2024
Q4
$6.71M Sell
169,400
-30,000
-15% -$1.14M 0.15% 203
2024
Q3
$6.79M Hold
199,400
0.15% 208
2024
Q2
$4.32M Buy
+199,400
New +$4.19M 0.1% 289
2019
Q2
Sell
-8,200
Closed -$205K 1391
2019
Q1
$205K Sell
8,200
-68,000
-89% -$1.3M ﹤0.01% 1224
2018
Q4
$959K Sell
76,200
-93,800
-55% -$1.11M 0.01% 745
2018
Q3
$1.62M Sell
170,000
-186,800
-52% -$2.06M 0.02% 695
2018
Q2
$3.33M Hold
356,800
0.03% 439
2018
Q1
$1.98M Hold
356,800
0.02% 591
2017
Q4
$2.33M Hold
356,800
0.03% 544
2017
Q3
$3.13M Hold
356,800
0.04% 419
2017
Q2
$2.97M Hold
356,800
0.04% 419
2017
Q1
$3.27M Buy
356,800
+246,800
+224% +$2.02M 0.04% 386
2016
Q4
$851K Sell
110,000
-41,000
-27% -$307K 0.01% 876
2016
Q3
$1.15M Hold
151,000
0.02% 742
2016
Q2
$760K Hold
151,000
0.01% 884
2016
Q1
$815K Buy
151,000
+107,500
+247% +$636K 0.01% 852
2015
Q4
$313K Buy
43,500
+2,500
+6% +$16.8K 0.01% 1196
2015
Q3
$192K Hold
41,000
﹤0.01% 1320
2015
Q2
$457K Hold
41,000
0.01% 1112
2015
Q1
$298K Hold
41,000
0.01% 1261
2014
Q4
$396K Buy
+41,000
New +$320K 0.01% 1149

Other funds holding VCYT

Bridgeway Capital Management's VCYT Position: Q2 2025 in Review

Bridgeway Capital Management sold out of Veracyte (VCYT) in Q2 2025, closing a stake of 128,100 shares — an estimated $3.8M sold.

Bridgeway Capital Management first reported a position in VCYT in Q4 2014 and held it in 22 quarters. The position peaked at $6.79M in Q3 2024. 278 funds tracked by Wall St. Rank hold VCYT as of Q2 2025.

  • Bridgeway Capital Management reported no remaining Veracyte position as of Q2 2025 after selling out during the quarter.
  • Bridgeway Capital Management sold 128,100 Veracyte shares in Q2 2025, an estimated $3.8M.
  • Bridgeway Capital Management first reported a position in Veracyte in Q4 2014 and held it in 22 quarters.
  • Bridgeway Capital Management's Veracyte position peaked at $6.79M in Q3 2024.
  • 278 funds tracked by Wall St. Rank held Veracyte as of Q2 2025.

Based on Bridgeway Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.